skip to Main Content
27 January 2021

Safeguarding continuity of care in the UK during the pandemic

As TeleCheck AF continues to gain traction across the continent, notable strides are being made in the UK, where recently published guidelines cite FibriCheck’s remote heart rhythm monitoring as an example of clinical best practice in the delivery of care for cardiovascular disease…

8 June 2020

First step towards the Asia-Pacific region

FibriCheck gains approval from Australia’s Therapeutic Goods Administration (TGA) FibriCheck, the mobile app capable of detecting heart rhythm disorders, was granted an Australian Register of Therapeutic Goods Certificate by the Australian Government Department of Health last week. As the first…

3 June 2020

FibriCheck guards you while you sleep

Night monitoring now closer than ever after successful beta test If you’re familiar with atrial fibrillation, you’ll know it can be a dangerous condition – the heart rhythm disorder is responsible for around 25% of all strokes1. You’ll also know…

15 May 2020

Scientific publications about the TeleCheck-AF project

At the beginning of April we launched the TeleCheck-AF programme, aimed to guarantee care for AF patients during the COVID-19 pandemic. Since then, some scientific articles have been published around the subject. You can find all the publications here: Delivering…

15 April 2020

Active hospitals in TeleCheck-AF

Under the TeleCheck-AF programme, use of the FibriCheck app has become standard operating procedure in a number of clinics throughout Europe. The following hospitals are currently active in the TeleCheck-AF project: The Netherlands Maastricht University Medical Center Rijnstate Hospital, Arnhem…

Back To Top